Medical Radiology and Radiation Safety. 2025. Vol. 70. № 3
DOI:10.33266/1024-6177-2025-70-3-5-10
Yu.B. Deshevoi, V.G. Lebedev, T.A. Nasonova, O.A. Dobrynina,
V.A. Brunchukov, I.V. Kobzeva, T.A. Astrelina, A.S. Samoylov
Study of the Efficacy of Cell Therapy for Severe Local Radiation Injuries in the Use of Drugs Affecting the State of Irradiated Tissues Before Cell Transplantation
A.I. Burnazyan Federal Medical Biophysical Center, Moscow, Russia
Contact person: Yu.B. Deshevoi, e-mail: Этот адрес электронной почты защищен от спам-ботов. У вас должен быть включен JavaScript для просмотра.
ABSTRACT
Purpose: To study the possibility of enhancing the therapeutic efficacy of multipotent mesenchymal stromal cells (MMSC) or stromal vascular fraction (SVF) cells in the treatment of severe local radiation injuries under the conditions of the use of pharmacological drugs, the use of which before and after cell transplantation can improve the condition of the irradiated tissue and thereby create favorable conditions for engraftment and functioning of the injected cells.
Material and methods: The work was carried out on male rats of the Wistar–Kyoto inbred line weighing 260–280 g. The animals were locally irradiated in the iliolumbar region of the back on an X-ray machine LNK-268 (RAP 100–10) at a dose of 110 Gy (voltage on the tube 30 kV, current 6.1 mA, Al filter with a thickness of 0.1 mm), at a dose rate of 20.0 Gy/min. The area of the irradiation field was 8.5 cm2. The severity of radiation damage to the skin and the effects of treatment were assessed in dynamics by clinical manifestations and using planimetry. After exposure to radiation, rats developed radiation ulcers of the skin that did not heal for a long time (up to 3–4 months). Cell and drug therapy were carried out in different periods after irradiation: from the 28th to the 49th or from the 35th to the 56th day. As drugs affecting the condition of the affected tissues surrounding the formed radiation ulcer, a complex antibiotic levotetrasulfin forte and drugs that affect the microcirculation and trophism of irradiated tissues – pentoxifylline and detralex were used. For cell therapy, syngeneous MMSC or SVF cells were used. In the cell therapy setting, the drugs were administered for one week before the first cell transplant, one week between the first and second transplantation, and one week after the second cell transplant.
Results and Conclusion: It was shown that the administration of drugs or the use of cell therapy when used separately stimulated the healing of radiation ulcers. Moreover, the therapeutic effect of cell therapy is more pronounced than with the use of drugs. However, in combination with drug and cell therapy, no enhancing effect of pharmacological agents on the therapeutic efficacy of transplantation of MMSC or SVF cells of adipose tissue was noted. Thus, these experiments showed the possibility of successful use of a complex antibiotic in combination with drugs that improve blood supply and trophism of irradiated tissues in the treatment of severe local radiation injuries and the inability of drug therapy under these conditions to enhance the therapeutic effectiveness of cell therapy.
Keywords: radiation ulcer, transplantation of cells, stromal-vascular fraction of adipose tissue, multipotent mesenchymal stromal cells, drug therapy
For citation: Deshevoi YuB, Lebedev VG, Nasonova TA, Dobrynina OA, Brunchukov VA, Kobzeva IV, Astrelina TA, Samoylov AS. Study of the Efficacy of Cell Therapy for Severe Local Radiation Injuries in the Use of Drugs Affecting the State of Irradiated Tissues Before Cell Transplantation. Medical Radiology and Radiation Safety. 2025;70(3):5–10. (In Russian). DOI:10.33266/1024-6177-2025-70-3-5-10
References
1. Radiatsionnaya Meditsina = Radiation Medicine. A Guide for Medical Researchers and Healthcare Organizers. Ed. L.A.Il’in. Vol.2. Moscow, IzdAT Publ., 2001. 432 p. (In Russ.).
2. Nadezhina N.M, Galstyan I.A. Lecheniye Mestnykh Luchevykh Porazheniy = Treatment of Local Radiation Injuries. Ed. K.V.Kotenko, A.Yu.Bushmanov. Moscow, FMBTS im. A.I.Burnazyana FMBA Rossii Publ., 2013. 99 p. (In Russ.).
3. Isakson M., C.de Blacam, Whelan D., McArdle A., Glove A.J. Mesenchymal Stem Cells and Cutaneous Wound Healing: Current Evidence and Future Potential. Review Article. Hundawi Publishing Corporation. Stem Cells International (Internet). 2015. Article ID 831095. 12 p. doi: 10.1155/2015/831095.
4. Bourin P., Bunnell B.A., Casteilla L., Dominici M., Katz A.J., March K.L., Rendl H., Rubin J.P., Yoshimura K., Gimble J.M. Stromal Cells from the Adipose Tissue-Derived Stromal Vascular Fraction and Cultured Expanded Adipose Tissue-Derived Stromal/Stem Cells: a Joint Statement of the International Federation for Adipose Therapeutics and the International Society for Cellular Therapy (ISCT). Cytotherapy. 2013;15:641-648.
5. Francois S., Mouiseddine M., Mathieu N., Semont A., Monti P., Dudoignon N., Sache A., Boutarfa A., Thierry D., Gourmelion P., Chapel A. Human Mesenchymal Stem Cells Favour Healing of the Cutaneous Radiation Syndrome in a Xenogenic Transplant Model. Annals of Hematology. 2007;86;1:1–8.
6. Kotenko K.V., Yeremin I.I., Moroz B.B., Bushmanov A.YU., Nadezhina N.M., Galstyan I.A., Deshevoy YU.B., Lebedev V.G., Nasonova T.A., Dobrynina O.A., Lyrshchikova A.V. Cellular Technologies in the Treatment of Radiation Burns: the Experience of the A.I.Burnazyan Federal Medical Biophysical Center. Kletochnaya Transplantologiya i Tkanevaya Inzheneriya = Cell Transplantology and Tissue Engineering. 2012;2;7:97–102 (In Russ.).
7. Deshevoy Yu.B., Nasonova T.A., Dobrynina O.A., Deyev R.V., Lebedev V.G., Lyrshchikova A.V., Astrelina T.A., Moroz B.B. Experience of Using Syngeneic Multipotent Mesenchymal Stem Cells (MMSC) of Adipose Tissue for the Treatment of Severe Radiation-Induced Skin Lesions in an Experiment. Radiatsionnaya Biologiya. Radioekologiya = Radiation biology. Radioecology. 2020;1;60:26-33 (In Russ.).
8. Deshevoy Yu.B., Lebedev V.G., Nasonova T.A., Dobrynina O.A., Lyrshchikova A.V., Astrelina T.A., Moroz B.B. (In Russ.). Comparative Efficacy of Syngeneic Cultured Mesenchymal Stem Cells (MMSC) and Freshly Isolated Cells of the Stromal-Vascular Fraction (SVF) of Adipose Tissue in the Treatment of Severe Local Radiation Injuries in an Experiment. Radiatsionnaya Biologiya. Radioekologiya = Radiation biology. Radioecology. 2021;2;61:151-157 (In Russ.).
9. Brunchukov V.A., Astrelina T.A., Nikitina I.V., Kobzeva I.V., Suchkova Yu.B., Usupzhanova D.Yu., Rastorguyeva A.A., Karaseva T.V., Gordeyev A.V., Maksimova L.A., Naumova L.A., Lishchuk S.V., Dubova Ye.A., Pavlov K.A., Brumberg V.A., Makhova A.Ye., Lomonosova Ye.Ye., Dobrovol’skaya Ye.I., Bushmanov A.Yu., Samoylov A.S. Experimental Treatment of Local Radiation Injuries with Mesenchymal Stem Cells and their Conditioned Environment. Meditsinskaya Radiologiya i Radiatsionnaya Bezopasnost’ = Medical Radiology and Radiation Safety. 2020;1;65:5-12 (In Russ.).
10. Cassia Noronha N., Mizukami A., Calary-Oliveira C. Priming Approaches to Improve the Efficacy of Mesenchymal Stromal Cell-Based Therapies. Stem Cell Research & Therapy. 2019;10:131-143.
11. Anh Bui T.V., Hwang Ji., Lee J. Challenges and Limitations of Strategies to Promote Therapeutic Potential of Human Mesenchymal Stem Cell for Stem Cells-Based Cardiac Repair. Korean Circ. J. 2021;51;2:97-113.
12. Zhao Y., Wang M., Liang F., Li J. Recent Strategies for Enhancing the Therapeutic Efficacy of Stem Cells in Wound Healing. Stem Cell Research & Therapy. 2021;12:588-599.
13. Kotenko K.V., Moroz B.B., Nasonova T.A., Dobrynina O.A, Lipengol’ts A.D., Gimadova T.I., Deshevoy Yu.B., Lebedev V.G., Lyrshchikova A.V., Yeremin I.I. Experimental Model of Severe Local Radiation Skin Lesions After Exposure to X-Rays. Patologicheskaya Fiziologiya i Eksperimental’naya Terapiya = Pathological Physiology and Experimental Therapy. 2013;4:121–123 (In Russ.).
14. Kolev M., Donchev N., Borov M. Experimental Research on the Toxicity of Pharmapentoxifylline. Exp. Med. Morhpol. 1990;29;4:57-61.
15. Product Monograph. PrTRENTAL®.ATC Code: C04AD03. Sanofi-Aventis Canada Inc. Date of Revision: March 30, 2011. 21 p.
16. Man M.Q., Yang B., Elias P.M. Benefits of Hesperidin for Cutaneous Functions. Hindawi Evidence-Based Complementary and Alternative Medicine. 2019. Article ID 2676307. 19 p. doi: 10.1155/2019/2676307.
17. Gunik A.V., Parshin P.A., Vostroilova G.A. Toxicity Parameters of the Complex antimicRobial drug Levoterasulfin Forte. Proceedings of the International Scientific and Practical Conference Aktual’nyye Problemy Bolezney Molodnyaka v Sovremennykh Usloviyakh = Current Problems of Diseases of Young Animals in Modern Conditions, Voronezh, September 23-25, 2002. Voronezh Publ., 2002. P.11 (In Russ.).
PDF (RUS) Full-text article (in Russian)
Conflict of interest. The authors declare no conflict of interest.
Financing. The study had no sponsorship.
Contribution. Article was prepared with equal participation of the authors.
Article received: 20.02.2025. Accepted for publication: 25.03.2025.